We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$33.6B
AUM Growth
+$255M
Cap. Flow
-$824M
Cap. Flow %
-2.45%
Top 10 Hldgs %
29.14%
Holding
1,152
New
97
Increased
418
Reduced
387
Closed
96

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$94.4M
2
ELV icon
Elevance Health
ELV
+$74.7M
3
PAYO icon
Payoneer
PAYO
+$71.5M
4
ABT icon
Abbott
ABT
+$64.2M
5
GE icon
GE Aerospace
GE
+$63.5M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$101M
2
AAPL icon
Apple
AAPL
+$98.8M
3
AMGN icon
Amgen
AMGN
+$85.8M
4
TXN icon
Texas Instruments
TXN
+$80.9M
5
BIIB icon
Biogen
BIIB
+$73M

Sector Composition

Rank Sector Weight
1 Technology 37.8%
2 Healthcare 15.65%
3 Consumer Discretionary 11.06%
4 Financials 8.19%
5 Industrials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAIA icon
526
Saia
SAIA
$9.41B
$4.84M 0.01%
10,200
-7,944
-44% -$3.7M
MMSI icon
527
Merit Medical Systems
MMSI
$5.15B
$4.83M 0.01%
56,225
-9,857
-15% -$775K
NAMS icon
528
NewAmsterdam Pharma
NAMS
$2.53B
$4.79M 0.01%
249,392
+141
+0.1% +$2.83K
CNK icon
529
Cinemark Holdings
CNK
$3.93B
$4.77M 0.01%
220,765
-92,750
-30% -$1.68M
FOUR icon
530
Shift4
FOUR
$3.34B
$4.65M 0.01%
63,383
-5,113
-7% -$339K
ENR icon
531
Energizer
ENR
$1.4B
$4.64M 0.01%
156,944
+30,292
+24% +$875K
MLTX icon
532
MoonLake Immunotherapeutics
MLTX
$1.04B
$4.59M 0.01%
104,314
+59
+0.1% +$2.5K
SANM icon
533
Sanmina
SANM
$10.3B
$4.57M 0.01%
69,053
-11,247
-14% -$719K
M icon
534
Macy's
M
$5.77B
$4.57M 0.01%
237,973
-172,751
-42% -$3.3M
APP icon
535
Applovin
APP
$111B
$4.56M 0.01%
54,807
+13,671
+33% +$1.06M
D icon
536
Dominion Energy
D
$56.2B
$4.55M 0.01%
92,807
-77
-0.1% -$3.92K
KFY icon
537
Korn Ferry
KFY
$4.25B
$4.54M 0.01%
+67,680
New +$4.35M
WEX icon
538
WEX
WEX
$6.82B
$4.52M 0.01%
25,542
-2,066
-7% -$421K
DRI icon
539
Darden Restaurants
DRI
$23.7B
$4.5M 0.01%
29,738
+14,282
+92% +$2.17M
QGEN icon
540
Qiagen
QGEN
$8.77B
$4.5M 0.01%
106,387
-12,767
-11% -$560K
ROL icon
541
Rollins
ROL
$16.2B
$4.48M 0.01%
91,760
-211,255
-70% -$9.75M
HAE icon
542
Haemonetics
HAE
$4.83B
$4.44M 0.01%
53,625
-50
-0.1% -$4.4K
WHR icon
543
Whirlpool
WHR
$2.15B
$4.43M 0.01%
43,329
-27,435
-39% -$2.67M
CAKE icon
544
Cheesecake Factory
CAKE
$4.81B
$4.4M 0.01%
112,088
+56,889
+103% +$2.11M
SIG icon
545
Signet Jewelers
SIG
$3.83B
$4.39M 0.01%
49,053
+46,268
+1,661% +$4.57M
OCUL icon
546
Ocular Therapeutix
OCUL
$2.24B
$4.37M 0.01%
638,665
+360
+0.1% +$2.22K
TFC icon
547
Truist Financial
TFC
$61.6B
$4.36M 0.01%
112,178
+21,907
+24% +$828K
CLX icon
548
Clorox
CLX
$10.5B
$4.35M 0.01%
31,906
+8,118
+34% +$1.13M
TPL icon
549
Texas Pacific Land
TPL
$25.6B
$4.35M 0.01%
17,778
+12,999
+272% +$2.73M
MKTX icon
550
MarketAxess Holdings
MKTX
$5.75B
$4.35M 0.01%
21,695
-949
-4% -$196K

Similar funds

Axa's Q2 2024 Portfolio in Review

As of Q2 2024, Axa held 1,152 positions worth $33.6B, up 0.76% from $33.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Axa's Q2 2024 filing shows 97 new, 418 increased, 387 reduced and 96 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 721,967 shares worth $27.8M. The largest sale was UnitedHealth, an estimated $101M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 721,967 shares worth $27.8M.
  • Axa added most to Advanced Micro Devices in Q2 2024, an estimated $94.4M increase.
  • Axa's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $101M.
  • Axa fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $46.4M.
  • Axa's ten largest holdings make up 29% of its $33.6B portfolio in Q2 2024.
  • Axa opened 97 new positions and closed 96 in Q2 2024.
  • Axa's portfolio value rose 0.76% quarter-over-quarter to $33.6B.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.